1 års avkastning (CAGR)
50.89%
Johnson & Johnson Exchange (NYSE, USD)
JNJ
280.78
+5.89 (+2.13%)
HealthcareDrug Manufacturers - General
Loading...
3 års avkastning (CAGR)
23.37%
5 års avkastning (CAGR)
11.59%
10 års avkastning (CAGR)
9.36%
Adobe 2026 Q3 – Er det sentimentet som driver prisen?
Les merMarkedsverdi
679.13B
Pris/omsetning
6.93
Ent verdi
778.11B
Pris/bok
-
Utbytte avkastning
1.90%
Vekst år
58
Utbytte vekst
4.89%
FCF-utbetaling
95.35%
Etterfølgende P/E
32.28
PEG
5.04
Fremtidig P/E
24.28
EPS-vekst
14.90%
Forretningsinnsikt
Betydning og metodikk for fundamental analyse (2025)
Les merSegment Revenues ($M)
Loading...
Operations comments
In 21Q1 JNJ COVID-19 Vaccine authorized by U.S. FDA for emergency use
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted emergency use listing by the World Health Organization
In 21Q1 JNJ Single-Shot COVID-19 Vaccine granted conditional marketing authorization by European Commission
The company has not provided an official guidance for COVID-19 Vaccine revenues and margins for 2021
Geographic Revenues ($M)
Loading...